Guangdong Lifestrong Pharmacy Co. Ltd. Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Guangdong Lifestrong Pharmacy Co. Ltd. cash flow conversion efficiency. Based on the latest financial reports, Guangdong Lifestrong Pharmacy Co. Ltd. (301111) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥7.75 Million ≈ $1.13 Million USD) by net assets (CN¥752.66 Million ≈ $110.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Guangdong Lifestrong Pharmacy Co. Ltd. (2017–2025)

Cash flow conversion efficiency of Guangdong Lifestrong Pharmacy Co. Ltd. from 2017 to 2025. This chart illustrates how Guangdong Lifestrong Pharmacy Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Guangdong Lifestrong Pharmacy Co. Ltd. stock price today for real-time trading data and today's change.

Guangdong Lifestrong Pharmacy Co. Ltd. Cash Flow Conversion Ratio Explained

Guangdong Lifestrong Pharmacy Co. Ltd. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Guangdong Lifestrong Pharmacy Co. Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangdong Lifestrong Pharmacy Co. Ltd. ranked by their cash flow conversion efficiency. Also see Guangdong Lifestrong Pharmacy Co. Ltd. (301111) total market value for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
China Datang Corporation Renewable Power Co. Limited
STU:DT7
0.046x
Shanghai Ailu Package Co. Ltd.
SHE:301062
N/A
Agriculture & Natural Solutions Acquisition Corporation Class A Ordinary Shares
NASDAQ:ANSC
0.006x
Keystone Technology Co Ltd
SHG:605588
0.055x
Tubacex S.A
MC:TUB
0.044x
Chieftek Precision Co Ltd
TW:1597
0.051x
China Railway High speed Electrification Equipment Co Ltd
SHG:688285
0.024x
Kaimei Electronic Corp
TW:2375
0.007x

Annual Cash Flow Conversion Efficiency for Guangdong Lifestrong Pharmacy Co. Ltd. (2017–2025)

The table below shows the annual cash flow conversion efficiency of Guangdong Lifestrong Pharmacy Co. Ltd. from 2017 to 2025. Review Guangdong Lifestrong Pharmacy Co. Ltd. free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥751.22 Million
≈ $109.93 Million
CN¥10.58 Million
≈ $1.55 Million
0.014x +236.51%
2024-12-31 CN¥766.75 Million
≈ $112.20 Million
CN¥3.21 Million
≈ $469.51K
0.004x +125.44%
2023-12-31 CN¥778.21 Million
≈ $113.88 Million
CN¥-12.80 Million
≈ $-1.87 Million
-0.016x -117.86%
2022-12-31 CN¥758.67 Million
≈ $111.02 Million
CN¥69.88 Million
≈ $10.23 Million
0.092x -3.44%
2021-12-31 CN¥750.85 Million
≈ $109.87 Million
CN¥71.63 Million
≈ $10.48 Million
0.095x -66.06%
2020-12-31 CN¥323.41 Million
≈ $47.32 Million
CN¥90.90 Million
≈ $13.30 Million
0.281x +56.80%
2019-12-31 CN¥271.68 Million
≈ $39.76 Million
CN¥48.70 Million
≈ $7.13 Million
0.179x -0.42%
2018-12-31 CN¥229.97 Million
≈ $33.65 Million
CN¥41.40 Million
≈ $6.06 Million
0.180x +325.19%
2017-12-31 CN¥166.37 Million
≈ $24.34 Million
CN¥7.04 Million
≈ $1.03 Million
0.042x --

About Guangdong Lifestrong Pharmacy Co. Ltd.

SHE:301111 China Drug Manufacturers - Specialty & Generic
Market Cap
$376.95 Million
CN¥2.58 Billion CNY
Market Cap Rank
#13379 Global
#3895 in China
Share Price
CN¥16.10
Change (1 day)
-6.94%
52-Week Range
CN¥16.10 - CN¥30.31
All Time High
CN¥56.05
About

Guangdong Lifestrong Pharmacy Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. It operates through Medical Services and Health Management; and Health Consumer Products segments. The company produces tablets, hard capsules, injections, and pills, and other related products. It also offers respiratory, pediatric, gynecology, urinary, and nutrition and… Read more